GB1140397A - Treating animals for helminthiasis - Google Patents

Treating animals for helminthiasis

Info

Publication number
GB1140397A
GB1140397A GB3866466A GB3866466A GB1140397A GB 1140397 A GB1140397 A GB 1140397A GB 3866466 A GB3866466 A GB 3866466A GB 3866466 A GB3866466 A GB 3866466A GB 1140397 A GB1140397 A GB 1140397A
Authority
GB
United Kingdom
Prior art keywords
oil
benzimidazole
thiazolyl
treating
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3866466A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1140397A publication Critical patent/GB1140397A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3866466A 1965-09-01 1966-08-30 Treating animals for helminthiasis Expired GB1140397A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48443465A 1965-09-01 1965-09-01

Publications (1)

Publication Number Publication Date
GB1140397A true GB1140397A (en) 1969-01-15

Family

ID=23924159

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3866466A Expired GB1140397A (en) 1965-09-01 1966-08-30 Treating animals for helminthiasis

Country Status (2)

Country Link
BE (1) BE686234A (cg-RX-API-DMAC7.html)
GB (1) GB1140397A (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022255464A1 (ja) * 2021-06-02 2022-12-08 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法
WO2022255463A1 (ja) * 2021-06-02 2022-12-08 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法
CN117412963A (zh) * 2021-06-02 2024-01-16 日本农药株式会社 苯并咪唑化合物或其盐类和包含该化合物的犬心丝虫病防治剂及其使用方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022255464A1 (ja) * 2021-06-02 2022-12-08 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法
WO2022255463A1 (ja) * 2021-06-02 2022-12-08 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法
CN117412963A (zh) * 2021-06-02 2024-01-16 日本农药株式会社 苯并咪唑化合物或其盐类和包含该化合物的犬心丝虫病防治剂及其使用方法
JP7595161B2 (ja) 2021-06-02 2024-12-05 日本農薬株式会社 ベンゾイミダゾール化合物又はその塩類及び該化合物を含有する犬糸状虫症防除剤並びにその使用方法

Also Published As

Publication number Publication date
BE686234A (cg-RX-API-DMAC7.html) 1967-02-28

Similar Documents

Publication Publication Date Title
NL187611C (nl) Sterilisatie-hulpstuk, bestemd voor plaatsing op het naaldhoudereinde van een injectiespuit.
UY23835A1 (es) Procedimiento para la preparacion de compuesto de acilo
ES2153836T3 (es) Composicion enmascaradora del sabor de agentes farmaceuticos amargos.
MX9303469A (es) Derivados de benzimidazol, procedimiento para su preparacion, composicion farmaceutica que los contiene y procedimiento para preparar de la misma.
ES2092646T3 (es) Metanoantracenos como antagonistas de dopamina.
GB1154744A (en) Disubstituted Aminoethanols
GB1314896A (en) Propanolamine derivatives
ES2110256T3 (es) Derivados heteroaromaticos triciclicos fundidos como ligandos de subtipos de receptores de dopamina.
JPS6452719A (en) Heterocyclic sulfide
Eyre et al. Release of dopamine from bovine lung by specific antigen and by compound 48/80
FR2549834B1 (fr) Derives de triazolo-pyrimidine, leur procede de preparation et leur application therapeutique en tant que tonicardiaques
IT7924233A0 (it) Dispositivo per l'alimentazione del lubrificante nella canna del cilindro di una macchina acombustione interna.
FR2184065A1 (en) Injectable anti-narcotic prepns - contg narcotic antagonists in vegetable oils
ES8503680A1 (es) Un procedimiento para la preparacion de un compuesto dotado de propiedades fungicidas
ATE101044T1 (de) Gefluegelcolibacillose-vakzin.
VOGT Histamine H2‐receptors in the brain and sleep produced by clonidine
GB1151896A (en) Method for Combating Lungworm in Animals.
GB1021071A (en) Thiocyano-phenyl-isothio-cyanates
KR950702561A (ko) 퀴놀린 및 나프티리딘 약물 전구체(quinoline and naphthyridine prodrugs)
ES373657A1 (es) Un procedimiento para la preparacion de derivados simetri- cos de di-hidrotriazina n-sustituidos.
ES2109244T3 (es) Medicamentos que contienen compuestos de 3,7-diazabiciclo(3,3,1)nonano.
GB1205796A (en) Poultry feeds and poultry feed additives containing 5-nitrofurfurylidenemethyl compounds
SU430527A1 (cg-RX-API-DMAC7.html)
RAO Protective Effects of BW 501 C 67 and BW 204 C 67 Against Lethal Effects of Exudates from Burnt Rat Skin
GB1083825A (en) Method of enhancing the activity of parentally administrable drugs